25 XP   0   0   10

Novo Nordisk A/S
Buy, Hold or Sell?

Let's analyse Novo Nordisk A/S together

PenkeI guess you are interested in Novo Nordisk A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Novo Nordisk A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Novo Nordisk A/S

I send you an email if I find something interesting about Novo Nordisk A/S.

Quick analysis of Novo Nordisk A/S (30 sec.)










What can you expect buying and holding a share of Novo Nordisk A/S? (30 sec.)

How much money do you get?

How much money do you get?
kr1.02
When do you have the money?
1 year
How often do you get paid?
70.0%

What is your share worth?

Current worth
kr23.90
Expected worth in 1 year
kr29.40
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
kr12.57
Return On Investment
1.4%

For what price can you sell your share?

Current Price per Share
kr881.30
Expected price per share
kr723.78 - kr913.02
How sure are you?
50%

1. Valuation of Novo Nordisk A/S (5 min.)




Live pricePrice per Share (EOD)

kr881.30

Intrinsic Value Per Share

kr31.52 - kr181.68

Total Value Per Share

kr55.42 - kr205.59

2. Growth of Novo Nordisk A/S (5 min.)




Is Novo Nordisk A/S growing?

Current yearPrevious yearGrowGrow %
How rich?$15.4b$10.9b$2.4b18.6%

How much money is Novo Nordisk A/S making?

Current yearPrevious yearGrowGrow %
Making money$3b$2b$1b33.6%
Net Profit Margin36.1%31.5%--

How much money comes from the company's main activities?

3. Financial Health of Novo Nordisk A/S (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#5 / 1031

Most Revenue
#2 / 1031

Most Profit
#1 / 1031

Most Efficient
#51 / 1031

What can you expect buying and holding a share of Novo Nordisk A/S? (5 min.)

Welcome investor! Novo Nordisk A/S's management wants to use your money to grow the business. In return you get a share of Novo Nordisk A/S.

What can you expect buying and holding a share of Novo Nordisk A/S?

First you should know what it really means to hold a share of Novo Nordisk A/S. And how you can make/lose money.

Speculation

The Price per Share of Novo Nordisk A/S is kr881.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Novo Nordisk A/S.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Novo Nordisk A/S, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr23.90. Based on the TTM, the Book Value Change Per Share is kr1.38 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.74 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr1.77 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Novo Nordisk A/S.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.710.1%0.680.1%0.440.1%0.420.0%0.340.0%
Usd Book Value Change Per Share0.450.1%0.200.0%0.110.0%0.100.0%0.060.0%
Usd Dividend Per Share0.000.0%0.260.0%0.420.0%0.290.0%0.230.0%
Usd Total Gains Per Share0.450.1%0.460.1%0.530.1%0.380.0%0.290.0%
Usd Price Per Share101.22-127.86-117.29-88.45-66.43-
Price to Earnings Ratio35.43-48.25-66.42-52.51-48.72-
Price-to-Total Gains Ratio224.63-295.15-237.00-250.04-284.96-
Price to Book Ratio29.21-44.06-48.89-39.85-38.41-
Price-to-Total Gains Ratio224.63-295.15-237.00-250.04-284.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share127.7885
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.260.29
Usd Book Value Change Per Share0.200.10
Usd Total Gains Per Share0.460.38
Gains per Quarter (7 shares)3.192.68
Gains per Year (7 shares)12.7610.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1763831
214111616512
322172924823
4292242321134
5362855401345
6433368481656
7503981561967
8574594652178
96550107732489
1072561208127100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%80.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%26.014.00.065.0%52.028.00.065.0%
Dividend per Share2.00.02.050.0%10.00.02.083.3%16.00.04.080.0%28.00.012.070.0%32.00.048.040.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%70.010.00.087.5%

Fundamentals of Novo Nordisk A/S

About Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Fundamental data was last updated by Penke on 2024-03-11 11:28:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Novo Nordisk A/S.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novo Nordisk A/S earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Novo Nordisk A/S to the Biotechnology industry mean.
  • A Net Profit Margin of 33.3% means that kr0.33 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novo Nordisk A/S:

  • The MRQ is 33.3%. The company is making a huge profit. +2
  • The TTM is 36.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.3%TTM36.1%-2.8%
TTM36.1%YOY31.5%+4.6%
TTM36.1%5Y33.4%+2.7%
5Y33.4%10Y33.2%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ33.3%-159.2%+192.5%
TTM36.1%-202.3%+238.4%
YOY31.5%-263.0%+294.5%
5Y33.4%-452.4%+485.8%
10Y33.2%-589.0%+622.2%
1.1.2. Return on Assets

Shows how efficient Novo Nordisk A/S is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novo Nordisk A/S to the Biotechnology industry mean.
  • 7.0% Return on Assets means that Novo Nordisk A/S generated kr0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novo Nordisk A/S:

  • The MRQ is 7.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.0%TTM7.3%-0.3%
TTM7.3%YOY6.2%+1.1%
TTM7.3%5Y7.4%0.0%
5Y7.4%10Y8.7%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0%-12.5%+19.5%
TTM7.3%-12.2%+19.5%
YOY6.2%-11.2%+17.4%
5Y7.4%-13.3%+20.7%
10Y8.7%-14.6%+23.3%
1.1.3. Return on Equity

Shows how efficient Novo Nordisk A/S is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novo Nordisk A/S to the Biotechnology industry mean.
  • 20.6% Return on Equity means Novo Nordisk A/S generated kr0.21 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novo Nordisk A/S:

  • The MRQ is 20.6%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 22.8%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.6%TTM22.8%-2.2%
TTM22.8%YOY18.6%+4.2%
TTM22.8%5Y19.3%+3.5%
5Y19.3%10Y20.0%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.6%-16.0%+36.6%
TTM22.8%-15.8%+38.6%
YOY18.6%-13.9%+32.5%
5Y19.3%-18.2%+37.5%
10Y20.0%-19.1%+39.1%

1.2. Operating Efficiency of Novo Nordisk A/S.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novo Nordisk A/S is operating .

  • Measures how much profit Novo Nordisk A/S makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novo Nordisk A/S to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novo Nordisk A/S:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM22.7%-22.7%
TTM22.7%YOY42.5%-19.8%
TTM22.7%5Y38.0%-15.3%
5Y38.0%10Y39.9%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM22.7%-208.5%+231.2%
YOY42.5%-280.2%+322.7%
5Y38.0%-459.9%+497.9%
10Y39.9%-596.9%+636.8%
1.2.2. Operating Ratio

Measures how efficient Novo Nordisk A/S is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.75 means that the operating costs are kr0.75 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.746. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.636. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.746TTM0.636+0.110
TTM0.636YOY0.575+0.061
TTM0.6365Y0.587+0.049
5Y0.58710Y0.579+0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7462.817-2.071
TTM0.6363.181-2.545
YOY0.5753.609-3.034
5Y0.5875.554-4.967
10Y0.5797.396-6.817

1.3. Liquidity of Novo Nordisk A/S.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novo Nordisk A/S is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.82 means the company has kr0.82 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.823. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.847. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.823TTM0.847-0.024
TTM0.847YOY0.914-0.067
TTM0.8475Y0.949-0.102
5Y0.94910Y1.096-0.147
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8233.987-3.164
TTM0.8474.440-3.593
YOY0.9145.569-4.655
5Y0.9496.158-5.209
10Y1.0966.492-5.396
1.3.2. Quick Ratio

Measures if Novo Nordisk A/S is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novo Nordisk A/S to the Biotechnology industry mean.
  • A Quick Ratio of 0.48 means the company can pay off kr0.48 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.475. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.601. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.475TTM0.601-0.126
TTM0.601YOY0.764-0.163
TTM0.6015Y0.713-0.112
5Y0.71310Y0.816-0.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4753.653-3.178
TTM0.6014.158-3.557
YOY0.7645.515-4.751
5Y0.7136.012-5.299
10Y0.8166.206-5.390

1.4. Solvency of Novo Nordisk A/S.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novo Nordisk A/S assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novo Nordisk A/S to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.66 means that Novo Nordisk A/S assets are financed with 66.1% credit (debt) and the remaining percentage (100% - 66.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novo Nordisk A/S:

  • The MRQ is 0.661. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.677. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.661TTM0.677-0.016
TTM0.677YOY0.665+0.012
TTM0.6775Y0.615+0.062
5Y0.61510Y0.565+0.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6610.336+0.325
TTM0.6770.330+0.347
YOY0.6650.267+0.398
5Y0.6150.367+0.248
10Y0.5650.378+0.187
1.4.2. Debt to Equity Ratio

Measures if Novo Nordisk A/S is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novo Nordisk A/S to the Biotechnology industry mean.
  • A Debt to Equity ratio of 195.1% means that company has kr1.95 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novo Nordisk A/S:

  • The MRQ is 1.951. The company is just able to pay all its debts with equity.
  • The TTM is 2.103. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.951TTM2.103-0.152
TTM2.103YOY1.990+0.113
TTM2.1035Y1.645+0.458
5Y1.64510Y1.357+0.288
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9510.376+1.575
TTM2.1030.398+1.705
YOY1.9900.334+1.656
5Y1.6450.431+1.214
10Y1.3570.476+0.881

2. Market Valuation of Novo Nordisk A/S

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Novo Nordisk A/S generates.

  • Above 15 is considered overpriced but always compare Novo Nordisk A/S to the Biotechnology industry mean.
  • A PE ratio of 35.43 means the investor is paying kr35.43 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novo Nordisk A/S:

  • The EOD is 44.724. Based on the earnings, the company is overpriced. -1
  • The MRQ is 35.427. Based on the earnings, the company is overpriced. -1
  • The TTM is 48.246. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD44.724MRQ35.427+9.297
MRQ35.427TTM48.246-12.819
TTM48.246YOY66.416-18.170
TTM48.2465Y52.511-4.265
5Y52.51110Y48.723+3.787
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD44.724-2.697+47.421
MRQ35.427-2.422+37.849
TTM48.246-2.709+50.955
YOY66.416-4.116+70.532
5Y52.511-6.257+58.768
10Y48.723-6.478+55.201
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Novo Nordisk A/S:

  • The EOD is -142.668. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -113.011. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 4.285. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-142.668MRQ-113.011-29.657
MRQ-113.011TTM4.285-117.296
TTM4.285YOY317.681-313.395
TTM4.2855Y82.994-78.708
5Y82.99410Y71.391+11.603
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-142.668-3.344-139.324
MRQ-113.011-2.939-110.072
TTM4.285-3.486+7.771
YOY317.681-5.592+323.273
5Y82.994-8.464+91.458
10Y71.391-8.872+80.263
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novo Nordisk A/S is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 29.21 means the investor is paying kr29.21 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Novo Nordisk A/S:

  • The EOD is 36.872. Based on the equity, the company is expensive. -2
  • The MRQ is 29.207. Based on the equity, the company is expensive. -2
  • The TTM is 44.060. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD36.872MRQ29.207+7.665
MRQ29.207TTM44.060-14.853
TTM44.060YOY48.886-4.827
TTM44.0605Y39.849+4.211
5Y39.84910Y38.414+1.435
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD36.8722.198+34.674
MRQ29.2072.042+27.165
TTM44.0602.121+41.939
YOY48.8862.907+45.979
5Y39.8493.682+36.167
10Y38.4144.114+34.300
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Novo Nordisk A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.1081.375+126%0.742+319%0.658+372%0.398+681%
Book Value Per Share--23.90220.622+16%16.558+44%15.022+59%11.750+103%
Current Ratio--0.8230.847-3%0.914-10%0.949-13%1.096-25%
Debt To Asset Ratio--0.6610.677-2%0.665-1%0.615+7%0.565+17%
Debt To Equity Ratio--1.9512.103-7%1.990-2%1.645+19%1.357+44%
Dividend Per Share---1.767-100%2.927-100%1.986-100%1.619-100%
Eps--4.9264.664+6%3.052+61%2.921+69%2.334+111%
Free Cash Flow Per Share---1.5443.892-140%3.522-144%2.690-157%2.157-172%
Free Cash Flow To Equity Per Share---3.8130.375-1118%0.677-663%0.425-996%0.205-1960%
Gross Profit Margin--1.0000.659+52%0.166+503%0.284+252%0.244+310%
Intrinsic Value_10Y_max--181.685--------
Intrinsic Value_10Y_min--31.518--------
Intrinsic Value_1Y_max--14.052--------
Intrinsic Value_1Y_min--7.749--------
Intrinsic Value_3Y_max--45.388--------
Intrinsic Value_3Y_min--19.446--------
Intrinsic Value_5Y_max--80.539--------
Intrinsic Value_5Y_min--26.845--------
Market Cap2985633000806.400-4%3112330815102.6003960610356615.800-21%3678399095000.000-15%2796860742823.160+11%2173228875911.580+43%
Net Profit Margin--0.3330.361-8%0.315+6%0.3340%0.332+0%
Operating Margin---0.227-100%0.425-100%0.380-100%0.399-100%
Operating Ratio--0.7460.636+17%0.575+30%0.587+27%0.579+29%
Pb Ratio36.872+21%29.20744.060-34%48.886-40%39.849-27%38.414-24%
Pe Ratio44.724+21%35.42748.246-27%66.416-47%52.511-33%48.723-27%
Price Per Share881.300+21%698.100881.800-21%808.875-14%610.025+14%458.148+52%
Price To Free Cash Flow Ratio-142.668-26%-113.0114.285-2737%317.681-136%82.994-236%71.391-258%
Price To Total Gains Ratio283.585+21%224.634295.148-24%236.999-5%250.037-10%284.964-21%
Quick Ratio--0.4750.601-21%0.764-38%0.713-33%0.816-42%
Return On Assets--0.0700.073-5%0.062+12%0.074-5%0.087-20%
Return On Equity--0.2060.228-9%0.186+11%0.193+7%0.200+3%
Total Gains Per Share--3.1083.142-1%3.669-15%2.644+18%2.017+54%
Usd Book Value--15451345000.00013408838750.000+15%10917340000.000+42%10007037250.000+54%8100845500.000+91%
Usd Book Value Change Per Share--0.4510.199+126%0.108+319%0.095+372%0.058+681%
Usd Book Value Per Share--3.4662.990+16%2.401+44%2.178+59%1.704+103%
Usd Dividend Per Share---0.256-100%0.424-100%0.288-100%0.235-100%
Usd Eps--0.7140.676+6%0.443+61%0.424+69%0.338+111%
Usd Free Cash Flow---998325000.0002537935000.000-139%2324857500.000-143%1792069500.000-156%1490574625.000-167%
Usd Free Cash Flow Per Share---0.2240.564-140%0.511-144%0.390-157%0.313-172%
Usd Free Cash Flow To Equity Per Share---0.5530.054-1118%0.098-663%0.062-996%0.030-1960%
Usd Market Cap432916785116.928-4%451287968189.877574288501709.291-21%533367868775.000-15%405544807709.358+11%315118187007.179+43%
Usd Price Per Share127.789+21%101.225127.861-21%117.287-14%88.454+14%66.431+52%
Usd Profit--3184635000.0003033508750.000+5%2012781250.000+58%1943391500.000+64%1609782750.000+98%
Usd Revenue--9550135000.0008419461250.000+13%6414582500.000+49%5792619500.000+65%4824954750.000+98%
Usd Total Gains Per Share--0.4510.456-1%0.532-15%0.383+18%0.292+54%
 EOD+3 -5MRQTTM+16 -20YOY+19 -175Y+19 -1710Y+20 -16

3.2. Fundamental Score

Let's check the fundamental score of Novo Nordisk A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.724
Price to Book Ratio (EOD)Between0-136.872
Net Profit Margin (MRQ)Greater than00.333
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.475
Current Ratio (MRQ)Greater than10.823
Debt to Asset Ratio (MRQ)Less than10.661
Debt to Equity Ratio (MRQ)Less than11.951
Return on Equity (MRQ)Greater than0.150.206
Return on Assets (MRQ)Greater than0.050.070
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Novo Nordisk A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.248
Ma 20Greater thanMa 50888.940
Ma 50Greater thanMa 100835.108
Ma 100Greater thanMa 200766.433
OpenGreater thanClose895.000
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Interest Expense  8,037,000-6,915,0001,122,000-841,000281,0001,887,0002,168,000-4,269,000-2,101,000
Interest Income  3,200,000-2,348,000852,000-205,000647,0002,671,0003,318,000-6,138,000-2,820,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in DKK. All numbers in thousands.

Summary
Total Assets314,486,000
Total Liabilities207,925,000
Total Stockholder Equity106,561,000
 As reported
Total Liabilities 207,925,000
Total Stockholder Equity+ 106,561,000
Total Assets = 314,486,000

Assets

Total Assets314,486,000
Total Current Assets139,646,000
Long-term Assets174,840,000
Total Current Assets
Cash And Cash Equivalents 14,392,000
Short-term Investments 15,838,000
Net Receivables 64,770,000
Inventory 31,811,000
Total Current Assets  (as reported)139,646,000
Total Current Assets  (calculated)126,811,000
+/- 12,835,000
Long-term Assets
Property Plant Equipment 90,961,000
Goodwill 4,464,000
Long Term Investments 1,663,000
Intangible Assets 55,942,000
Long-term Assets  (as reported)174,840,000
Long-term Assets  (calculated)153,030,000
+/- 21,810,000

Liabilities & Shareholders' Equity

Total Current Liabilities169,655,000
Long-term Liabilities38,270,000
Total Stockholder Equity106,561,000
Total Current Liabilities
Short Long Term Debt 5,304,000
Accounts payable 25,606,000
Other Current Liabilities 29,977,000
Total Current Liabilities  (as reported)169,655,000
Total Current Liabilities  (calculated)60,887,000
+/- 108,768,000
Long-term Liabilities
Long term Debt 15,976,000
Capital Lease Obligations Min Short Term Debt5,726,000
Long-term Liabilities Other 189,000
Long-term Liabilities  (as reported)38,270,000
Long-term Liabilities  (calculated)21,891,000
+/- 16,379,000
Total Stockholder Equity
Retained Earnings 104,839,000
Total Stockholder Equity (as reported)106,561,000
Total Stockholder Equity (calculated)104,839,000
+/- 1,722,000
Other
Capital Stock451,000
Common Stock Shares Outstanding 4,458,288
Net Debt 6,888,000
Net Invested Capital 127,841,000
Net Working Capital -30,009,000
Property Plant and Equipment Gross 138,583,000



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-311986-12-311986-09-301986-06-301986-03-311985-12-311985-09-30
> Total Assets 
0
7,362,133
0
0
0
8,150,175
0
0
0
8,266,854
0
0
0
9,226,283
0
0
0
11,660,255
0
0
0
12,499,842
0
0
0
15,272,205
0
0
0
16,775,801
0
0
0
19,240,043
0
0
0
21,129,303
0
0
0
20,145,170
0
0
0
21,046,601
0
0
0
25,685,911
0
0
0
27,340,292
0
0
0
31,043,249
0
0
0
24,601,020
0
0
0
28,829,689
0
0
0
31,453,254
0
0
0
34,488,779
33,611,590
34,245,414
35,541,292
37,695,767
36,518,408
37,665,234
40,152,666
41,896,251
41,313,923
43,169,052
43,768,036
44,696,246
44,748,298
48,330,468
48,407,691
47,795,444
47,488,344
48,501,996
48,950,215
50,726,464
50,205,000
51,246,000
52,589,000
54,742,000
54,155,000
57,048,000
57,162,000
61,402,000
59,001,000
61,528,000
62,013,000
64,698,000
61,210,000
60,978,000
66,620,000
65,669,000
62,447,000
64,289,000
68,134,000
70,337,000
63,241,000
63,681,000
71,283,000
77,062,000
77,457,000
81,313,000
85,195,000
91,799,000
82,368,000
88,269,000
87,340,000
97,539,000
94,213,000
97,825,000
97,891,000
102,355,000
93,558,000
103,248,000
101,895,000
110,769,000
110,135,000
117,909,000
124,908,000
125,612,000
126,256,000
136,121,000
139,947,000
144,922,000
141,387,000
158,095,000
174,084,000
194,508,000
197,136,000
218,928,000
242,836,000
241,257,000
250,025,000
280,753,000
300,101,000
314,486,000
314,486,000300,101,000280,753,000250,025,000241,257,000242,836,000218,928,000197,136,000194,508,000174,084,000158,095,000141,387,000144,922,000139,947,000136,121,000126,256,000125,612,000124,908,000117,909,000110,135,000110,769,000101,895,000103,248,00093,558,000102,355,00097,891,00097,825,00094,213,00097,539,00087,340,00088,269,00082,368,00091,799,00085,195,00081,313,00077,457,00077,062,00071,283,00063,681,00063,241,00070,337,00068,134,00064,289,00062,447,00065,669,00066,620,00060,978,00061,210,00064,698,00062,013,00061,528,00059,001,00061,402,00057,162,00057,048,00054,155,00054,742,00052,589,00051,246,00050,205,00050,726,46448,950,21548,501,99647,488,34447,795,44448,407,69148,330,46844,748,29844,696,24643,768,03643,169,05241,313,92341,896,25140,152,66637,665,23436,518,40837,695,76735,541,29234,245,41433,611,59034,488,77900031,453,25400028,829,68900024,601,02000031,043,24900027,340,29200025,685,91100021,046,60100020,145,17000021,129,30300019,240,04300016,775,80100015,272,20500012,499,84200011,660,2550009,226,2830008,266,8540008,150,1750007,362,1330
   > Total Current Assets 
0
4,289,274
0
0
0
4,348,963
0
0
0
4,192,563
0
0
0
4,891,538
0
0
0
6,392,756
0
0
0
6,637,202
0
0
0
8,487,647
0
0
0
10,578,571
0
0
0
9,201,110
0
0
0
13,204,066
0
0
0
9,634,213
0
0
0
9,753,085
0
0
0
12,842,271
0
0
0
13,062,860
0
0
0
15,931,937
0
0
0
12,529,114
0
0
0
13,825,887
0
0
0
13,751,952
0
0
0
16,301,314
15,183,521
15,550,586
16,522,901
17,873,797
16,328,108
16,721,641
18,156,474
19,529,730
18,868,600
20,314,848
20,522,333
20,839,413
20,928,675
22,933,044
23,253,241
24,332,412
24,726,234
26,232,026
27,122,783
29,137,092
28,663,000
29,727,000
31,008,000
32,666,000
31,383,000
33,780,000
33,923,000
37,293,000
35,467,000
37,875,000
38,794,000
39,591,000
36,353,000
35,918,000
40,895,000
40,163,000
35,799,000
36,525,000
40,907,000
42,058,000
34,506,000
34,215,000
41,171,000
46,293,000
43,461,000
47,337,000
51,488,000
55,140,000
46,381,000
52,626,000
51,576,000
59,766,000
55,648,000
58,974,000
57,094,000
60,080,000
49,915,000
57,502,000
54,135,000
59,067,000
52,734,000
58,720,000
63,400,000
62,456,000
63,193,000
73,579,000
73,667,000
65,809,000
61,389,000
77,146,000
91,213,000
85,595,000
86,537,000
102,979,000
119,482,000
108,194,000
113,943,000
137,551,000
142,199,000
139,646,000
139,646,000142,199,000137,551,000113,943,000108,194,000119,482,000102,979,00086,537,00085,595,00091,213,00077,146,00061,389,00065,809,00073,667,00073,579,00063,193,00062,456,00063,400,00058,720,00052,734,00059,067,00054,135,00057,502,00049,915,00060,080,00057,094,00058,974,00055,648,00059,766,00051,576,00052,626,00046,381,00055,140,00051,488,00047,337,00043,461,00046,293,00041,171,00034,215,00034,506,00042,058,00040,907,00036,525,00035,799,00040,163,00040,895,00035,918,00036,353,00039,591,00038,794,00037,875,00035,467,00037,293,00033,923,00033,780,00031,383,00032,666,00031,008,00029,727,00028,663,00029,137,09227,122,78326,232,02624,726,23424,332,41223,253,24122,933,04420,928,67520,839,41320,522,33320,314,84818,868,60019,529,73018,156,47416,721,64116,328,10817,873,79716,522,90115,550,58615,183,52116,301,31400013,751,95200013,825,88700012,529,11400015,931,93700013,062,86000012,842,2710009,753,0850009,634,21300013,204,0660009,201,11000010,578,5710008,487,6470006,637,2020006,392,7560004,891,5380004,192,5630004,348,9630004,289,2740
       Cash And Cash Equivalents 
0
2,105,644
0
0
0
1,994,223
0
0
0
2,047,814
0
0
0
2,520,696
0
0
0
2,947,606
0
0
0
4,338,354
0
0
0
6,035,909
0
0
0
5,818,998
0
0
0
5,706,441
0
0
0
6,684,733
0
0
0
2,999,885
0
0
0
1,572,002
0
0
0
1,122,911
0
0
0
798,675
0
0
0
1,973,934
0
0
0
1,275,371
0
0
0
1,654,094
0
0
0
1,422,616
0
0
0
1,265,318
1,492,372
2,016,945
2,944,320
3,457,320
2,321,913
2,449,471
3,498,548
3,296,982
3,096,543
3,280,731
3,540,970
3,271,697
3,147,673
3,828,592
4,173,257
4,827,616
4,442,884
6,033,129
7,138,132
8,804,783
8,049,000
8,863,000
10,228,000
11,296,000
9,527,000
11,391,000
12,352,000
12,017,000
10,297,000
12,572,000
14,913,000
13,408,000
8,432,000
9,068,000
13,482,000
11,553,000
7,184,000
8,070,000
9,428,000
10,728,000
2,640,000
5,001,000
12,104,000
14,396,000
5,984,000
11,836,000
15,484,000
16,923,000
4,818,000
13,167,000
14,537,000
18,690,000
16,763,000
21,327,000
19,134,000
18,852,000
10,513,000
18,393,000
16,401,000
15,638,000
9,055,000
14,457,000
18,757,000
15,475,000
9,765,000
24,874,000
25,480,000
12,757,000
5,683,000
24,229,000
29,493,000
10,720,000
13,394,000
22,758,000
28,465,000
12,653,000
14,936,000
21,574,000
30,144,000
14,392,000
14,392,00030,144,00021,574,00014,936,00012,653,00028,465,00022,758,00013,394,00010,720,00029,493,00024,229,0005,683,00012,757,00025,480,00024,874,0009,765,00015,475,00018,757,00014,457,0009,055,00015,638,00016,401,00018,393,00010,513,00018,852,00019,134,00021,327,00016,763,00018,690,00014,537,00013,167,0004,818,00016,923,00015,484,00011,836,0005,984,00014,396,00012,104,0005,001,0002,640,00010,728,0009,428,0008,070,0007,184,00011,553,00013,482,0009,068,0008,432,00013,408,00014,913,00012,572,00010,297,00012,017,00012,352,00011,391,0009,527,00011,296,00010,228,0008,863,0008,049,0008,804,7837,138,1326,033,1294,442,8844,827,6164,173,2573,828,5923,147,6733,271,6973,540,9703,280,7313,096,5433,296,9823,498,5482,449,4712,321,9133,457,3202,944,3202,016,9451,492,3721,265,3180001,422,6160001,654,0940001,275,3710001,973,934000798,6750001,122,9110001,572,0020002,999,8850006,684,7330005,706,4410005,818,9980006,035,9090004,338,3540002,947,6060002,520,6960002,047,8140001,994,2230002,105,6440
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,395,120
0
0
0
318,496
0
0
0
1,832,937
827,753
524,040
526,626
532,318
528,753
523,128
521,060
1,720,987
1,292,792
1,558,639
1,482,267
1,830,794
1,679,875
1,727,267
1,864,647
2,557,000
2,941,463
2,739,315
1,652,149
1,380,094
1,264,000
1,091,000
1,635,000
1,530,000
648,000
591,000
637,000
4,034,000
4,304,000
3,921,000
2,992,000
4,094,000
4,871,000
3,322,000
4,063,000
4,552,000
4,039,000
3,053,000
4,054,000
3,741,000
2,528,000
1,522,000
1,516,000
1,509,000
1,204,000
3,000
2,024,000
3,542,000
4,032,000
2,053,000
2,042,000
2,009,000
1,003,000
3,000
3,000
0
0
0
0
0
0
0
0
0
0
0
0
0
1,983,000
2,987,000
5,897,000
6,765,000
6,752,000
8,279,000
9,008,000
10,921,000
12,835,000
14,834,000
17,451,000
15,838,000
15,838,00017,451,00014,834,00012,835,00010,921,0009,008,0008,279,0006,752,0006,765,0005,897,0002,987,0001,983,00000000000000003,0003,0001,003,0002,009,0002,042,0002,053,0004,032,0003,542,0002,024,0003,0001,204,0001,509,0001,516,0001,522,0002,528,0003,741,0004,054,0003,053,0004,039,0004,552,0004,063,0003,322,0004,871,0004,094,0002,992,0003,921,0004,304,0004,034,000637,000591,000648,0001,530,0001,635,0001,091,0001,264,0001,380,0941,652,1492,739,3152,941,4632,557,0001,864,6471,727,2671,679,8751,830,7941,482,2671,558,6391,292,7921,720,987521,060523,128528,753532,318526,626524,040827,7531,832,937000318,4960001,395,12000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
888,332
0
0
0
1,146,899
0
0
0
1,102,247
0
0
0
1,244,881
0
0
0
2,117,704
0
0
0
1,113,035
0
0
0
1,054,968
0
0
0
3,092,343
0
0
0
1,437,143
0
0
0
4,040,150
0
0
0
4,362,108
0
0
0
5,670,883
0
0
0
4,769,634
0
0
0
5,704,731
0
0
0
6,528,028
0
0
0
4,708,444
0
0
0
6,031,595
0
0
0
4,699,586
0
0
0
4,387,223
6,090,326
5,935,059
5,960,452
4,571,346
6,138,127
6,092,906
6,469,833
6,121,165
6,580,924
7,384,564
7,305,456
6,498,190
7,478,513
8,427,302
8,341,291
7,313,020
8,050,072
8,217,946
9,102,707
8,724,545
9,420,000
9,873,000
9,397,000
7,862,000
8,867,000
9,312,000
9,006,000
9,150,000
9,685,000
10,097,000
9,522,000
12,608,000
13,417,000
14,070,000
13,831,000
13,584,000
14,425,000
14,878,000
16,904,000
15,174,000
18,097,000
16,777,000
16,258,000
17,528,000
23,731,000
22,294,000
20,631,000
21,613,000
23,119,000
23,179,000
20,187,000
24,197,000
22,536,000
20,855,000
20,153,000
23,551,000
21,311,000
22,332,000
21,568,000
26,889,000
26,560,000
27,000,000
26,522,000
29,152,000
35,569,000
30,146,000
28,394,000
32,184,000
33,917,000
30,223,000
35,452,000
46,799,000
44,166,000
46,639,000
53,510,000
57,505,000
57,921,000
70,521,000
52,602,000
64,770,000
64,770,00052,602,00070,521,00057,921,00057,505,00053,510,00046,639,00044,166,00046,799,00035,452,00030,223,00033,917,00032,184,00028,394,00030,146,00035,569,00029,152,00026,522,00027,000,00026,560,00026,889,00021,568,00022,332,00021,311,00023,551,00020,153,00020,855,00022,536,00024,197,00020,187,00023,179,00023,119,00021,613,00020,631,00022,294,00023,731,00017,528,00016,258,00016,777,00018,097,00015,174,00016,904,00014,878,00014,425,00013,584,00013,831,00014,070,00013,417,00012,608,0009,522,00010,097,0009,685,0009,150,0009,006,0009,312,0008,867,0007,862,0009,397,0009,873,0009,420,0008,724,5459,102,7078,217,9468,050,0727,313,0208,341,2918,427,3027,478,5136,498,1907,305,4567,384,5646,580,9246,121,1656,469,8336,092,9066,138,1274,571,3465,960,4525,935,0596,090,3264,387,2230004,699,5860006,031,5950004,708,4440006,528,0280005,704,7310004,769,6340005,670,8830004,362,1080004,040,1500001,437,1430003,092,3430001,054,9680001,113,0350002,117,7040001,244,8810001,102,2470001,146,899000888,3320
       Other Current Assets 
0
0
0
0
0
-734
0
0
0
610
0
0
0
687
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,234,197
0
0
0
1,917,712
0
0
0
2,543,195
0
0
0
2,574,805
0
0
0
0
0
0
0
997,954
0
0
0
1,915,715
0
-6,093
0
1,640,855
0
0
0
94,560
6,156
-5,838
11,764
5,651
5,581
5,501
0
603,452
0
-4,739
0
593,761
0
0
0
1,962,000
2,068,000
2,440,000
2,164,000
2,403,000
2,222,000
2,293,000
2,312,000
48,000
87,000
27,000
105,000
931,000
558,000
864,000
1,181,000
2,863,000
942,000
216,000
8,000
1,503,000
254,000
379,000
587,000
304,000
1,417,000
592,000
558,000
529,000
302,000
1,761,000
2,574,000
2,304,000
2,224,000
643,000
244,000
204,000
281,000
134,000
612,000
188,000
598,000
750,000
1,688,000
2,332,000
1,153,000
885,000
1,472,000
1,690,000
1,936,000
3,597,000
5,277,000
2,727,000
2,636,000
2,602,000
0
0
002,602,0002,636,0002,727,0005,277,0003,597,0001,936,0001,690,0001,472,000885,0001,153,0002,332,0001,688,000750,000598,000188,000612,000134,000281,000204,000244,000643,0002,224,0002,304,0002,574,0001,761,000302,000529,000558,000592,0001,417,000304,000587,000379,000254,0001,503,0008,000216,000942,0002,863,0001,181,000864,000558,000931,000105,00027,00087,00048,0002,312,0002,293,0002,222,0002,403,0002,164,0002,440,0002,068,0001,962,000000593,7610-4,7390603,45205,5015,5815,65111,764-5,8386,15694,5600001,640,8550-6,09301,915,715000997,95400000002,574,8050002,543,1950001,917,7120004,234,19700000000000000000000000000000000000687000610000-73400000
   > Long-term Assets 
0
3,072,859
0
0
0
3,801,212
0
0
0
4,074,291
0
0
0
4,334,744
0
0
0
5,267,499
0
0
0
5,862,640
0
0
0
6,784,559
0
0
0
6,197,230
0
0
0
10,038,933
0
0
0
7,925,237
0
0
0
10,510,957
0
0
0
11,293,516
0
0
0
12,843,640
0
0
0
14,277,432
0
0
0
15,111,312
0
0
0
12,071,906
0
0
0
15,003,802
0
0
0
17,701,303
0
0
0
18,187,465
18,428,070
18,694,827
19,018,391
19,821,970
20,190,300
20,943,593
21,996,193
22,366,521
22,445,323
22,854,204
23,245,704
23,856,833
23,819,623
25,397,424
25,154,450
23,463,032
22,762,110
22,269,971
21,827,433
21,589,371
21,542,000
21,519,000
21,581,000
22,076,000
22,772,000
23,268,000
23,239,000
24,109,000
23,534,000
23,653,000
23,219,000
25,107,000
24,857,000
25,060,000
25,725,000
25,506,000
26,648,000
27,764,000
27,227,000
28,279,000
28,735,000
29,466,000
30,112,000
30,769,000
33,996,000
33,976,000
33,707,000
36,659,000
35,987,000
35,643,000
35,764,000
37,773,000
38,565,000
38,851,000
40,797,000
42,275,000
43,643,000
45,746,000
47,760,000
51,702,000
57,401,000
59,189,000
61,508,000
63,156,000
63,063,000
62,542,000
66,280,000
79,113,000
79,998,000
80,949,000
82,871,000
108,913,000
110,599,000
115,949,000
123,354,000
133,063,000
136,082,000
143,202,000
157,902,000
174,840,000
174,840,000157,902,000143,202,000136,082,000133,063,000123,354,000115,949,000110,599,000108,913,00082,871,00080,949,00079,998,00079,113,00066,280,00062,542,00063,063,00063,156,00061,508,00059,189,00057,401,00051,702,00047,760,00045,746,00043,643,00042,275,00040,797,00038,851,00038,565,00037,773,00035,764,00035,643,00035,987,00036,659,00033,707,00033,976,00033,996,00030,769,00030,112,00029,466,00028,735,00028,279,00027,227,00027,764,00026,648,00025,506,00025,725,00025,060,00024,857,00025,107,00023,219,00023,653,00023,534,00024,109,00023,239,00023,268,00022,772,00022,076,00021,581,00021,519,00021,542,00021,589,37121,827,43322,269,97122,762,11023,463,03225,154,45025,397,42423,819,62323,856,83323,245,70422,854,20422,445,32322,366,52121,996,19320,943,59320,190,30019,821,97019,018,39118,694,82718,428,07018,187,46500017,701,30300015,003,80200012,071,90600015,111,31200014,277,43200012,843,64000011,293,51600010,510,9570007,925,23700010,038,9330006,197,2300006,784,5590005,862,6400005,267,4990004,334,7440004,074,2910003,801,2120003,072,8590
       Property Plant Equipment 
0
2,976,048
0
0
0
3,638,943
0
0
0
3,984,063
0
0
0
4,245,382
0
0
0
5,139,314
0
0
0
5,713,619
0
0
0
6,527,321
0
0
0
8,116,615
0
0
0
9,627,836
0
0
0
10,135,644
0
0
0
10,124,680
0
0
0
10,807,440
0
0
0
12,332,852
0
0
0
13,830,327
0
0
0
14,704,697
0
0
0
10,900,811
0
0
0
13,591,974
0
0
0
16,179,599
0
0
0
16,874,846
16,295,247
16,683,976
17,121,340
17,681,724
18,253,457
18,764,918
19,459,125
19,914,273
20,105,986
20,087,182
20,304,699
20,353,461
20,331,510
20,386,150
20,354,421
19,632,646
19,018,001
19,009,332
18,814,379
18,684,756
18,684,000
18,760,000
18,845,000
19,226,000
19,512,000
20,060,000
20,004,000
20,507,000
20,217,000
20,175,000
20,307,000
20,931,000
20,731,000
21,085,000
21,323,000
21,539,000
21,838,000
21,751,000
21,870,000
21,882,000
21,905,000
22,168,000
22,612,000
23,136,000
23,464,000
23,632,000
23,977,000
25,545,000
25,863,000
27,125,000
28,223,000
30,179,000
31,096,000
31,888,000
33,128,000
35,247,000
36,134,000
37,971,000
39,555,000
41,891,000
47,350,000
48,204,000
50,300,000
50,551,000
50,863,000
50,502,000
49,925,000
50,269,000
51,429,000
52,076,000
52,863,000
55,362,000
56,399,000
59,556,000
63,641,000
66,671,000
70,014,000
75,024,000
81,461,000
90,961,000
90,961,00081,461,00075,024,00070,014,00066,671,00063,641,00059,556,00056,399,00055,362,00052,863,00052,076,00051,429,00050,269,00049,925,00050,502,00050,863,00050,551,00050,300,00048,204,00047,350,00041,891,00039,555,00037,971,00036,134,00035,247,00033,128,00031,888,00031,096,00030,179,00028,223,00027,125,00025,863,00025,545,00023,977,00023,632,00023,464,00023,136,00022,612,00022,168,00021,905,00021,882,00021,870,00021,751,00021,838,00021,539,00021,323,00021,085,00020,731,00020,931,00020,307,00020,175,00020,217,00020,507,00020,004,00020,060,00019,512,00019,226,00018,845,00018,760,00018,684,00018,684,75618,814,37919,009,33219,018,00119,632,64620,354,42120,386,15020,331,51020,353,46120,304,69920,087,18220,105,98619,914,27319,459,12518,764,91818,253,45717,681,72417,121,34016,683,97616,295,24716,874,84600016,179,59900013,591,97400010,900,81100014,704,69700013,830,32700012,332,85200010,807,44000010,124,68000010,135,6440009,627,8360008,116,6150006,527,3210005,713,6190005,139,3140004,245,3820003,984,0630003,638,9430002,976,0480
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,952
0
0
0
66,482
0
0
0
0
0
0
0
0
0
0
0
70,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,346,000
0
0
0
5,092,000
0
0
0
4,464,000
4,464,0000005,092,0000004,346,000000000000000000000000000000000000000000000070,0000000000000066,48200016,9520000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,040,000
2,002,000
2,213,000
1,762,000
1,560,000
1,521,000
1,544,000
1,773,000
1,706,000
2,098,000
2,062,000
1,808,000
1,725,000
1,850,000
1,633,000
1,648,000
1,749,000
1,839,000
1,778,000
1,441,000
1,279,000
1,242,000
1,239,000
1,343,000
1,211,000
1,479,000
1,471,000
1,663,000
1,663,0001,471,0001,479,0001,211,0001,343,0001,239,0001,242,0001,279,0001,441,0001,778,0001,839,0001,749,0001,648,0001,633,0001,850,0001,725,0001,808,0002,062,0002,098,0001,706,0001,773,0001,544,0001,521,0001,560,0001,762,0002,213,0002,002,0002,040,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
34,063
0
0
0
13,217
0
0
0
14,632
0
0
0
26,809
0
0
0
55,503
0
0
0
79,709
0
0
0
150,203
0
0
0
158,694
0
0
0
188,901
0
0
0
189,116
0
0
0
154,622
0
0
0
220,402
0
0
0
256,763
0
0
0
236,928
0
0
0
177,432
0
0
0
32,085
0
0
0
16,708
0
0
0
240,641
0
0
0
218,770
344,393
408,264
233,391
318,293
402,312
412,348
471,436
485,406
517,117
560,410
664,667
621,566
636,232
737,114
752,126
603,452
698,775
800,942
841,961
791,682
912,000
911,000
999,000
1,037,000
1,131,000
1,190,000
1,276,000
1,388,000
1,484,000
1,479,000
1,462,000
1,489,000
1,470,000
1,449,000
1,472,000
1,495,000
0
0
0
1,615,000
0
0
0
1,378,000
0
0
0
2,158,000
0
0
0
2,714,000
2,771,000
2,647,000
2,615,000
3,325,000
4,035,000
4,197,000
4,610,000
5,145,000
5,302,000
5,900,000
5,033,000
5,835,000
0
0
0
20,657,000
0
0
0
38,825,000
0
0
0
46,324,000
0
0
0
55,942,000
55,942,00000046,324,00000038,825,00000020,657,0000005,835,0005,033,0005,900,0005,302,0005,145,0004,610,0004,197,0004,035,0003,325,0002,615,0002,647,0002,771,0002,714,0000002,158,0000001,378,0000001,615,0000001,495,0001,472,0001,449,0001,470,0001,489,0001,462,0001,479,0001,484,0001,388,0001,276,0001,190,0001,131,0001,037,000999,000911,000912,000791,682841,961800,942698,775603,452752,126737,114636,232621,566664,667560,410517,117485,406471,436412,348402,312318,293233,391408,264344,393218,770000240,64100016,70800032,085000177,432000236,928000256,763000220,402000154,622000189,116000188,901000158,694000150,20300079,70900055,50300026,80900014,63200013,21700034,0630
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,658,000
2,314,000
2,841,000
1,941,000
1,914,000
2,057,000
2,051,000
2,893,000
3,043,000
2,987,000
4,113,000
4,962,000
4,637,000
4,405,000
5,307,000
6,539,000
6,463,000
6,762,000
7,704,000
8,939,000
9,577,000
10,561,000
11,550,000
13,633,000
14,368,000
15,950,000
0
0
0015,950,00014,368,00013,633,00011,550,00010,561,0009,577,0008,939,0007,704,0006,762,0006,463,0006,539,0005,307,0004,405,0004,637,0004,962,0004,113,0002,987,0003,043,0002,893,0002,051,0002,057,0001,914,0001,941,0002,841,0002,314,0002,658,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
2,446,276
0
0
0
4,075,822
0
0
0
3,101,290
0
0
0
3,700,274
0
0
0
5,400,971
0
0
0
5,471,027
0
0
0
5,770,393
0
0
0
6,219,811
0
0
0
7,285,599
0
0
0
7,996,384
0
0
0
5,724,886
0
0
0
5,023,378
0
0
0
7,511,866
0
0
0
9,304,501
0
0
0
12,412,864
0
0
0
8,855,405
0
0
0
8,746,648
0
0
0
8,556,927
0
0
0
9,194,249
9,727,604
9,316,946
9,916,134
11,008,547
10,776,206
12,087,340
13,584,789
14,303,731
14,263,800
14,243,744
15,463,804
14,567,247
15,068,646
14,835,792
15,256,675
15,572,130
16,265,395
15,440,639
16,802,146
17,668,408
18,860,000
17,160,000
17,715,000
19,008,000
21,239,000
23,413,000
22,898,000
24,437,000
24,233,000
24,562,000
26,585,000
27,250,000
28,852,000
29,644,000
30,960,000
25,037,000
28,646,000
28,932,000
29,009,000
27,768,000
29,658,000
27,020,000
33,316,000
36,768,000
45,349,000
42,202,000
42,086,000
44,830,000
45,084,000
45,684,000
46,013,000
52,270,000
53,912,000
49,389,000
50,945,000
52,540,000
49,320,000
54,167,000
54,383,000
58,930,000
62,816,000
64,824,000
71,955,000
68,019,000
71,857,000
76,067,000
80,374,000
81,597,000
82,891,000
92,536,000
107,972,000
123,762,000
130,586,000
144,476,000
166,156,000
157,771,000
170,151,000
190,280,000
207,110,000
207,925,000
207,925,000207,110,000190,280,000170,151,000157,771,000166,156,000144,476,000130,586,000123,762,000107,972,00092,536,00082,891,00081,597,00080,374,00076,067,00071,857,00068,019,00071,955,00064,824,00062,816,00058,930,00054,383,00054,167,00049,320,00052,540,00050,945,00049,389,00053,912,00052,270,00046,013,00045,684,00045,084,00044,830,00042,086,00042,202,00045,349,00036,768,00033,316,00027,020,00029,658,00027,768,00029,009,00028,932,00028,646,00025,037,00030,960,00029,644,00028,852,00027,250,00026,585,00024,562,00024,233,00024,437,00022,898,00023,413,00021,239,00019,008,00017,715,00017,160,00018,860,00017,668,40816,802,14615,440,63916,265,39515,572,13015,256,67514,835,79215,068,64614,567,24715,463,80414,243,74414,263,80014,303,73113,584,78912,087,34010,776,20611,008,5479,916,1349,316,9469,727,6049,194,2490008,556,9270008,746,6480008,855,40500012,412,8640009,304,5010007,511,8660005,023,3780005,724,8860007,996,3840007,285,5990006,219,8110005,770,3930005,471,0270005,400,9710003,700,2740003,101,2900004,075,8220002,446,2760
   > Total Current Liabilities 
0
1,602,763
0
0
0
2,196,142
0
0
0
2,117,924
0
0
0
2,727,603
0
0
0
3,646,679
0
0
0
4,167,962
0
0
0
3,856,193
0
0
0
3,423,531
0
0
0
3,691,044
0
0
0
4,578,918
0
0
0
3,937,037
0
0
0
3,673,565
0
0
0
5,314,657
0
0
0
5,485,637
0
0
0
6,564,993
0
0
0
6,416,960
0
0
0
5,989,825
0
0
0
5,959,415
0
0
0
6,645,875
6,936,205
6,678,465
7,265,049
7,331,714
7,448,514
8,930,107
9,317,056
10,565,470
10,508,548
10,227,475
11,493,448
10,159,779
10,654,091
10,550,630
10,764,809
10,657,576
11,586,438
11,028,351
12,306,393
12,987,858
14,141,000
12,475,000
12,935,000
13,415,000
15,520,000
18,288,000
16,929,000
18,476,000
18,253,000
18,600,000
20,355,000
20,779,000
21,993,000
23,853,000
26,226,000
21,638,000
25,626,000
25,420,000
25,659,000
24,225,000
26,397,000
23,748,000
30,031,000
33,689,000
41,989,000
38,593,000
38,523,000
40,873,000
41,074,000
41,528,000
41,592,000
47,436,000
48,903,000
43,824,000
45,127,000
47,056,000
44,168,000
49,179,000
49,425,000
54,164,000
54,760,000
56,595,000
63,087,000
58,983,000
63,187,000
67,284,000
70,948,000
70,273,000
72,384,000
72,798,000
88,328,000
99,516,000
95,602,000
109,655,000
130,257,000
120,940,000
131,961,000
156,618,000
172,552,000
169,655,000
169,655,000172,552,000156,618,000131,961,000120,940,000130,257,000109,655,00095,602,00099,516,00088,328,00072,798,00072,384,00070,273,00070,948,00067,284,00063,187,00058,983,00063,087,00056,595,00054,760,00054,164,00049,425,00049,179,00044,168,00047,056,00045,127,00043,824,00048,903,00047,436,00041,592,00041,528,00041,074,00040,873,00038,523,00038,593,00041,989,00033,689,00030,031,00023,748,00026,397,00024,225,00025,659,00025,420,00025,626,00021,638,00026,226,00023,853,00021,993,00020,779,00020,355,00018,600,00018,253,00018,476,00016,929,00018,288,00015,520,00013,415,00012,935,00012,475,00014,141,00012,987,85812,306,39311,028,35111,586,43810,657,57610,764,80910,550,63010,654,09110,159,77911,493,44810,227,47510,508,54810,565,4709,317,0568,930,1077,448,5147,331,7147,265,0496,678,4656,936,2056,645,8750005,959,4150005,989,8250006,416,9600006,564,9930005,485,6370005,314,6570003,673,5650003,937,0370004,578,9180003,691,0440003,423,5310003,856,1930004,167,9620003,646,6790002,727,6030002,117,9240002,196,1420001,602,7630
       Short-term Debt 
0
63,644
0
0
0
62,411
0
0
0
1,044,940
0
0
0
1,260,004
0
0
0
1,809,794
0
0
0
1,719,515
0
0
0
1,357,148
0
0
0
996,700
0
0
0
960,134
0
0
0
1,455,159
0
0
0
725,448
0
0
0
117,945
0
0
0
1,339,962
0
0
0
922,871
0
0
0
1,145,917
0
0
0
818,162
0
0
0
827,047
0
0
0
566,215
0
0
0
975,596
791,501
499,666
436,860
510,366
425,301
596,982
856,028
1,443,611
1,175,825
326,906
299,983
339,036
195,334
99,015
151,470
404,006
618,510
464,451
804,893
1,337,300
1,451,000
453,000
229,000
418,000
1,036,000
3,268,000
1,001,000
1,720,000
1,008,000
885,000
1,692,000
351,000
383,000
388,000
588,000
500,000
300,000
716,000
670,000
215,000
804,000
406,000
284,000
720,000
594,000
736,000
630,000
1,073,000
406,000
406,000
456,000
229,000
613,000
1,683,000
260,000
1,694,000
228,000
247,000
337,000
515,000
1,114,000
1,255,000
1,416,000
1,474,000
1,244,000
1,408,000
1,468,000
7,459,000
6,823,000
1,301,000
1,350,000
13,684,000
1,396,000
1,256,000
1,833,000
1,466,000
1,251,000
6,289,000
0
0
006,289,0001,251,0001,466,0001,833,0001,256,0001,396,00013,684,0001,350,0001,301,0006,823,0007,459,0001,468,0001,408,0001,244,0001,474,0001,416,0001,255,0001,114,000515,000337,000247,000228,0001,694,000260,0001,683,000613,000229,000456,000406,000406,0001,073,000630,000736,000594,000720,000284,000406,000804,000215,000670,000716,000300,000500,000588,000388,000383,000351,0001,692,000885,0001,008,0001,720,0001,001,0003,268,0001,036,000418,000229,000453,0001,451,0001,337,300804,893464,451618,510404,006151,47099,015195,334339,036299,983326,9061,175,8251,443,611856,028596,982425,301510,366436,860499,666791,501975,596000566,215000827,047000818,1620001,145,917000922,8710001,339,962000117,945000725,4480001,455,159000960,134000996,7000001,357,1480001,719,5150001,809,7940001,260,0040001,044,94000062,41100063,6440
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
613,000
1,683,000
260,000
1,694,000
228,000
247,000
0
0
1,114,000
1,255,000
1,416,000
659,000
1,244,000
1,408,000
1,468,000
6,684,000
6,823,000
1,301,000
1,350,000
12,862,000
1,396,000
1,256,000
1,833,000
480,000
1,251,000
6,289,000
6,613,000
5,304,000
5,304,0006,613,0006,289,0001,251,000480,0001,833,0001,256,0001,396,00012,862,0001,350,0001,301,0006,823,0006,684,0001,468,0001,408,0001,244,000659,0001,416,0001,255,0001,114,00000247,000228,0001,694,000260,0001,683,000613,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
653,266
0
0
0
739,779
0
0
0
2,153,977
0
0
0
926,838
0
0
0
1,029,496
0
0
0
2,722,230
0
0
0
781,533
0
0
0
581,312
0
0
0
768,104
0
0
0
1,005,449
0
0
0
978,586
0
0
0
969,065
0
0
0
863,478
0
0
0
1,011,072
694,829
810,434
736,080
1,070,123
1,023,021
1,187,809
992,496
1,500,347
1,403,602
1,243,409
1,152,874
1,712,132
1,506,865
1,595,247
1,509,476
1,948,434
1,567,521
1,611,362
1,519,765
2,284,108
1,744,000
1,660,000
1,537,000
2,242,000
1,959,000
2,355,000
2,005,000
2,906,000
2,822,000
2,662,000
2,300,000
3,291,000
2,560,000
2,642,000
2,689,000
3,859,000
3,079,000
2,901,000
2,931,000
4,092,000
3,490,000
2,988,000
2,988,000
4,950,000
4,014,000
3,932,000
3,845,000
4,927,000
3,740,000
5,333,000
4,462,000
6,011,000
3,782,000
4,257,000
4,530,000
5,610,000
4,117,000
5,830,000
4,846,000
6,756,000
4,222,000
5,269,000
5,894,000
6,358,000
5,344,000
8,961,000
6,123,000
5,717,000
6,800,000
7,616,000
8,877,000
8,870,000
6,679,000
14,654,000
8,310,000
15,587,000
10,050,000
17,788,000
20,106,000
25,606,000
25,606,00020,106,00017,788,00010,050,00015,587,0008,310,00014,654,0006,679,0008,870,0008,877,0007,616,0006,800,0005,717,0006,123,0008,961,0005,344,0006,358,0005,894,0005,269,0004,222,0006,756,0004,846,0005,830,0004,117,0005,610,0004,530,0004,257,0003,782,0006,011,0004,462,0005,333,0003,740,0004,927,0003,845,0003,932,0004,014,0004,950,0002,988,0002,988,0003,490,0004,092,0002,931,0002,901,0003,079,0003,859,0002,689,0002,642,0002,560,0003,291,0002,300,0002,662,0002,822,0002,906,0002,005,0002,355,0001,959,0002,242,0001,537,0001,660,0001,744,0002,284,1081,519,7651,611,3621,567,5211,948,4341,509,4761,595,2471,506,8651,712,1321,152,8741,243,4091,403,6021,500,347992,4961,187,8091,023,0211,070,123736,080810,434694,8291,011,072000863,478000969,065000978,5860001,005,449000768,104000581,312000781,5330002,722,2300001,029,496000926,8380002,153,977000739,779000653,266000000000000000000000
       Other Current Liabilities 
0
1,539,119
0
0
0
2,133,731
0
0
0
1,072,984
0
0
0
1,467,599
0
0
0
1,836,885
0
0
0
1,795,181
0
0
0
1,759,266
0
0
0
272,854
0
0
0
1,804,073
0
0
0
2,094,262
0
0
0
489,359
0
0
0
2,774,086
0
0
0
3,393,383
0
0
0
3,794,662
0
0
0
4,413,627
0
0
0
4,620,211
0
0
0
4,193,713
0
0
0
3,206,194
0
0
0
3,849,168
5,449,875
5,368,365
6,092,109
5,641,469
6,000,192
7,145,316
7,468,532
7,621,512
7,929,121
8,657,161
10,040,591
8,108,611
8,951,892
8,856,369
9,103,863
8,182,400
9,400,407
8,952,538
9,981,735
9,286,211
7,556,000
9,607,000
10,036,000
10,054,000
11,864,000
12,052,000
12,652,000
7,954,000
7,810,000
7,373,000
8,203,000
10,026,000
9,748,000
10,042,000
9,731,000
48,000
11,425,000
9,781,000
9,337,000
16,935,000
11,671,000
10,117,000
12,729,000
2,607,000
20,101,000
15,189,000
14,016,000
1,382,000
15,503,000
14,085,000
13,449,000
2,578,000
18,293,000
14,308,000
13,879,000
309,000
15,719,000
14,974,000
14,946,000
2,024,000
16,993,000
14,746,000
16,232,000
15,819,000
16,454,000
13,991,000
16,300,000
18,370,000
17,343,000
14,591,000
19,239,000
21,784,000
87,527,000
93,745,000
120,114,000
103,887,000
120,660,000
24,066,000
28,693,000
29,977,000
29,977,00028,693,00024,066,000120,660,000103,887,000120,114,00093,745,00087,527,00021,784,00019,239,00014,591,00017,343,00018,370,00016,300,00013,991,00016,454,00015,819,00016,232,00014,746,00016,993,0002,024,00014,946,00014,974,00015,719,000309,00013,879,00014,308,00018,293,0002,578,00013,449,00014,085,00015,503,0001,382,00014,016,00015,189,00020,101,0002,607,00012,729,00010,117,00011,671,00016,935,0009,337,0009,781,00011,425,00048,0009,731,00010,042,0009,748,00010,026,0008,203,0007,373,0007,810,0007,954,00012,652,00012,052,00011,864,00010,054,00010,036,0009,607,0007,556,0009,286,2119,981,7358,952,5389,400,4078,182,4009,103,8638,856,3698,951,8928,108,61110,040,5918,657,1617,929,1217,621,5127,468,5327,145,3166,000,1925,641,4696,092,1095,368,3655,449,8753,849,1680003,206,1940004,193,7130004,620,2110004,413,6270003,794,6620003,393,3830002,774,086000489,3590002,094,2620001,804,073000272,8540001,759,2660001,795,1810001,836,8850001,467,5990001,072,9840002,133,7310001,539,1190
   > Long-term Liabilities 
0
843,512
0
0
0
1,879,680
0
0
0
983,365
0
0
0
972,671
0
0
0
1,754,291
0
0
0
1,303,066
0
0
0
1,914,200
0
0
0
2,796,281
0
0
0
3,594,555
0
0
0
3,417,466
0
0
0
1,787,849
0
0
0
1,349,813
0
0
0
2,197,209
0
0
0
3,818,864
0
0
0
5,847,871
0
0
0
2,438,445
0
0
0
2,756,823
0
0
0
2,597,512
0
0
0
2,548,374
2,791,399
2,638,481
2,651,085
3,676,833
3,327,692
3,157,233
4,267,733
3,738,260
3,755,252
4,016,269
3,970,357
4,407,468
4,414,555
4,285,162
4,491,866
4,914,554
4,678,957
4,412,288
4,495,752
4,680,550
4,719,000
4,685,000
4,780,000
5,593,000
5,719,000
5,125,000
5,969,000
5,961,000
5,980,000
5,962,000
6,230,000
6,471,000
6,859,000
5,791,000
4,734,000
3,399,000
3,020,000
3,512,000
3,350,000
3,543,000
3,261,000
3,272,000
3,285,000
3,079,000
3,360,000
3,609,000
3,563,000
3,957,000
4,010,000
4,156,000
4,421,000
4,834,000
5,009,000
5,565,000
5,818,000
5,484,000
5,152,000
4,988,000
4,958,000
4,766,000
8,056,000
8,229,000
8,868,000
9,036,000
8,670,000
8,783,000
9,426,000
11,324,000
10,507,000
19,738,000
19,644,000
24,246,000
34,984,000
34,821,000
35,899,000
36,831,000
38,190,000
33,662,000
34,558,000
38,270,000
38,270,00034,558,00033,662,00038,190,00036,831,00035,899,00034,821,00034,984,00024,246,00019,644,00019,738,00010,507,00011,324,0009,426,0008,783,0008,670,0009,036,0008,868,0008,229,0008,056,0004,766,0004,958,0004,988,0005,152,0005,484,0005,818,0005,565,0005,009,0004,834,0004,421,0004,156,0004,010,0003,957,0003,563,0003,609,0003,360,0003,079,0003,285,0003,272,0003,261,0003,543,0003,350,0003,512,0003,020,0003,399,0004,734,0005,791,0006,859,0006,471,0006,230,0005,962,0005,980,0005,961,0005,969,0005,125,0005,719,0005,593,0004,780,0004,685,0004,719,0004,680,5504,495,7524,412,2884,678,9574,914,5544,491,8664,285,1624,414,5554,407,4683,970,3574,016,2693,755,2523,738,2604,267,7333,157,2333,327,6923,676,8332,651,0852,638,4812,791,3992,548,3740002,597,5120002,756,8230002,438,4450005,847,8710003,818,8640002,197,2090001,349,8130001,787,8490003,417,4660003,594,5550002,796,2810001,914,2000001,303,0660001,754,291000972,671000983,3650001,879,680000843,5120
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,009,000
5,565,000
5,818,000
5,484,000
5,152,000
4,988,000
4,958,000
4,766,000
4,852,000
5,252,000
5,941,000
6,027,000
5,804,000
6,048,000
6,790,000
8,427,000
7,675,000
7,275,000
7,246,000
11,285,000
10,900,000
10,643,000
11,763,000
12,513,000
13,923,000
14,247,000
0
0
0014,247,00013,923,00012,513,00011,763,00010,643,00010,900,00011,285,0007,246,0007,275,0007,675,0008,427,0006,790,0006,048,0005,804,0006,027,0005,941,0005,252,0004,852,0004,766,0004,958,0004,988,0005,152,0005,484,0005,818,0005,565,0005,009,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
4,915,858
0
0
0
4,074,353
0
0
0
5,165,564
0
0
0
5,526,009
0
0
0
6,259,285
0
0
0
7,028,237
0
0
0
9,501,220
0
0
0
10,555,363
0
0
0
11,953,764
0
0
0
13,131,704
0
0
0
14,409,200
0
0
0
16,014,884
0
0
0
18,118,584
0
0
0
17,970,827
0
0
0
18,556,455
0
0
0
15,745,616
0
0
0
20,083,040
0
0
0
22,896,327
0
0
0
25,294,531
23,883,986
24,928,468
25,625,158
26,687,220
25,742,201
25,577,894
26,567,877
27,592,520
27,050,123
28,925,308
28,304,232
30,128,999
29,679,652
33,494,676
33,151,016
32,223,314
31,222,949
33,061,357
32,148,070
33,058,056
31,345,000
34,086,000
34,874,000
35,734,000
32,916,000
33,635,000
34,264,000
36,965,000
34,768,000
36,966,000
35,428,000
37,448,000
32,358,000
31,334,000
35,660,000
40,632,000
33,801,000
35,357,000
39,125,000
42,569,000
33,583,000
36,661,000
37,967,000
40,294,000
32,108,000
39,111,000
43,109,000
46,969,000
37,284,000
42,585,000
41,327,000
45,269,000
40,301,000
48,436,000
46,946,000
49,815,000
44,238,000
49,081,000
47,512,000
51,839,000
47,319,000
53,085,000
52,953,000
57,593,000
54,399,000
60,054,000
59,573,000
63,325,000
58,496,000
65,559,000
66,112,000
70,746,000
66,550,000
74,452,000
76,680,000
83,486,000
79,874,000
90,473,000
92,991,000
106,561,000
106,561,00092,991,00090,473,00079,874,00083,486,00076,680,00074,452,00066,550,00070,746,00066,112,00065,559,00058,496,00063,325,00059,573,00060,054,00054,399,00057,593,00052,953,00053,085,00047,319,00051,839,00047,512,00049,081,00044,238,00049,815,00046,946,00048,436,00040,301,00045,269,00041,327,00042,585,00037,284,00046,969,00043,109,00039,111,00032,108,00040,294,00037,967,00036,661,00033,583,00042,569,00039,125,00035,357,00033,801,00040,632,00035,660,00031,334,00032,358,00037,448,00035,428,00036,966,00034,768,00036,965,00034,264,00033,635,00032,916,00035,734,00034,874,00034,086,00031,345,00033,058,05632,148,07033,061,35731,222,94932,223,31433,151,01633,494,67629,679,65230,128,99928,304,23228,925,30827,050,12327,592,52026,567,87725,577,89425,742,20126,687,22025,625,15824,928,46823,883,98625,294,53100022,896,32700020,083,04000015,745,61600018,556,45500017,970,82700018,118,58400016,014,88400014,409,20000013,131,70400011,953,76400010,555,3630009,501,2200007,028,2370006,259,2850005,526,0090005,165,5640004,074,3530004,915,8580
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
754,092
0
0
0
754,087
0
0
0
753,993
0
0
0
710,091
0
0
0
707,769
0
0
0
709,524
706,913
706,845
706,158
713,415
706,919
707,762
707,153
706,046
707,957
677,162
676,431
672,421
675,299
649,100
647,664
649,478
646,839
635,066
635,442
636,555
634,000
620,000
620,000
620,000
620,000
600,000
600,000
600,000
600,000
580,000
580,000
580,000
580,000
560,000
560,000
560,000
560,000
550,000
550,000
550,000
550,000
530,000
530,000
530,000
530,000
520,000
520,000
520,000
520,000
510,000
510,000
510,000
510,000
500,000
500,000
500,000
500,000
490,000
490,000
490,000
490,000
480,000
480,000
480,000
480,000
470,000
470,000
470,000
470,000
462,000
462,000
462,000
462,000
456,000
456,000
456,000
456,000
451,000
0
0
00451,000456,000456,000456,000456,000462,000462,000462,000462,000470,000470,000470,000470,000480,000480,000480,000480,000490,000490,000490,000490,000500,000500,000500,000500,000510,000510,000510,000510,000520,000520,000520,000520,000530,000530,000530,000530,000550,000550,000550,000550,000560,000560,000560,000560,000580,000580,000580,000580,000600,000600,000600,000600,000620,000620,000620,000620,000634,000636,555635,442635,066646,839649,478647,664649,100675,299672,421676,431677,162707,957706,046707,153707,762706,919713,415706,158706,845706,913709,524000707,769000710,091000753,993000754,087000754,09200000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
194,892
0
0
0
547,083
0
0
0
64,170
0
0
0
400,992
0
0
0
608,681
0
0
0
863,254
163,134
152,337
257,329
609,147
-2,281,682
-129,243
6,203
25,216
443,243
706,350
658,785
678,072
602,746
731,613
793,911
900,064
1,123,705
1,279,611
-381,265
-1,064,491
0
0
0
0
0
0
0
0
0
0
0
0
518,000
0
509,000
1,088,000
752,000
691,000
774,000
903,000
691,000
32,000
-1,297,000
-1,502,000
-3,199,000
-756,000
-200,000
-357,000
706,000
-431,000
-233,000
-1,343,000
-935,000
927,000
1,192,000
349,000
100,000
-2,074,000
-1,977,000
-2,046,000
-1,742,000
-948,000
-1,241,000
-694,000
-924,000
-427,000
-742,000
-911,000
-2,262,000
-2,079,000
-2,260,000
-1,714,000
-517,000
833,000
2,555,000
2,449,000
2,354,000
1,907,000
0
0
001,907,0002,354,0002,449,0002,555,000833,000-517,000-1,714,000-2,260,000-2,079,000-2,262,000-911,000-742,000-427,000-924,000-694,000-1,241,000-948,000-1,742,000-2,046,000-1,977,000-2,074,000100,000349,0001,192,000927,000-935,000-1,343,000-233,000-431,000706,000-357,000-200,000-756,000-3,199,000-1,502,000-1,297,00032,000691,000903,000774,000691,000752,0001,088,000509,0000518,000000000000000-1,064,491-381,2651,279,6111,123,705900,064793,911731,613602,746678,072658,785706,350443,24325,2166,203-129,243-2,281,682609,147257,329152,337163,134863,254000608,681000400,99200064,170000547,083000194,89200000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
2,046,481
0
0
0
1,189,485
0
0
0
2,050,253
0
0
0
2,067,012
0
0
0
2,201,619
0
0
0
2,191,414
0
0
0
3,373,652
0
0
0
3,390,914
0
0
0
3,411,090
0
0
0
3,398,615
0
0
0
3,396,138
0
0
0
3,405,508
0
0
0
3,525,531
0
0
0
2,564,804
0
0
0
2,565,374
0
0
0
2,574,805
0
0
0
2,556,327
0
0
0
2,555,046
0
0
0
2,572,025
2,513,468
2,534,892
2,525,413
2,535,368
2,523,069
-55,390
-62,031
-63,040
-61,562
-29,188
-41,174
-33,904
-39,067
-16,503
-20,892
-25,570
-23,607
-18,957
-21,181
-26,746
-980,000
97,000
689,000
-32,000
-34,000
-18,000
-26,000
268,000
910,000
946,000
-7,000
-243,000
-27,000
-65,000
-16,000
-17,000
-19,000
-14,000
-17,000
-21,000
-23,000
-6,000
-9,000
-11,000
-13,000
-6,000
-8,000
-10,000
-12,000
-4,000
-6,000
-9,000
-13,000
-5,000
-8,000
-11,000
-14,000
-6,000
-8,000
-11,000
-13,000
-5,000
-7,000
-10,000
-11,000
-3,000
-5,000
-8,000
-9,000
-3,000
-4,000
-6,000
-7,000
-3,000
-4,000
-6,000
-6,000
-3,000
0
0
00-3,000-6,000-6,000-4,000-3,000-7,000-6,000-4,000-3,000-9,000-8,000-5,000-3,000-11,000-10,000-7,000-5,000-13,000-11,000-8,000-6,000-14,000-11,000-8,000-5,000-13,000-9,000-6,000-4,000-12,000-10,000-8,000-6,000-13,000-11,000-9,000-6,000-23,000-21,000-17,000-14,000-19,000-17,000-16,000-65,000-27,000-243,000-7,000946,000910,000268,000-26,000-18,000-34,000-32,000689,00097,000-980,000-26,746-21,181-18,957-23,607-25,570-20,892-16,503-39,067-33,904-41,174-29,188-61,562-63,040-62,031-55,3902,523,0692,535,3682,525,4132,534,8922,513,4682,572,0250002,555,0460002,556,3270002,574,8050002,565,3740002,564,8040003,525,5310003,405,5080003,396,1380003,398,6150003,411,0900003,390,9140003,373,6520002,191,4140002,201,6190002,067,0120002,050,2530001,189,4850002,046,4810



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue232,261,000
Cost of Revenue-35,765,000
Gross Profit196,496,000196,496,000
 
Operating Income (+$)
Gross Profit196,496,000
Operating Expense-129,687,000
Operating Income102,574,00066,809,000
 
Operating Expense (+$)
Research Development32,443,000
Selling General Administrative61,598,000
Selling And Marketing Expenses0
Operating Expense129,687,00094,041,000
 
Net Interest Income (+$)
Interest Income1,069,000
Interest Expense-542,000
Other Finance Cost-197,000
Net Interest Income330,000
 
Pretax Income (+$)
Operating Income102,574,000
Net Interest Income330,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)104,674,000100,804,000
EBIT - interestExpense = -542,000
83,683,000
84,225,000
Interest Expense542,000
Earnings Before Interest and Taxes (EBIT)0105,216,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax104,674,000
Tax Provision-20,991,000
Net Income From Continuing Ops83,683,00083,683,000
Net Income83,683,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,770,000-330,000
 

Technical Analysis of Novo Nordisk A/S
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Novo Nordisk A/S. The general trend of Novo Nordisk A/S is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Novo Nordisk A/S's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Novo Nordisk A/S.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 913.02.

The bearish price targets are: 827.93 > 727.16 > 723.78.

Tweet this
Novo Nordisk A/S Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Novo Nordisk A/S. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Novo Nordisk A/S Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Novo Nordisk A/S. The current macd is 15.79.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Novo Nordisk A/S price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Novo Nordisk A/S. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Novo Nordisk A/S price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Novo Nordisk A/S Daily Moving Average Convergence/Divergence (MACD) ChartNovo Nordisk A/S Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Novo Nordisk A/S. The current adx is 18.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Novo Nordisk A/S shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Novo Nordisk A/S Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Novo Nordisk A/S. The current sar is 877.31.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Novo Nordisk A/S Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Novo Nordisk A/S. The current rsi is 52.25. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Novo Nordisk A/S Daily Relative Strength Index (RSI) ChartNovo Nordisk A/S Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Novo Nordisk A/S. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Novo Nordisk A/S price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Novo Nordisk A/S Daily Stochastic Oscillator ChartNovo Nordisk A/S Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Novo Nordisk A/S. The current cci is -10.82206862.

Novo Nordisk A/S Daily Commodity Channel Index (CCI) ChartNovo Nordisk A/S Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Novo Nordisk A/S. The current cmo is -6.27047708.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Novo Nordisk A/S Daily Chande Momentum Oscillator (CMO) ChartNovo Nordisk A/S Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Novo Nordisk A/S. The current willr is -80.62283737.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Novo Nordisk A/S Daily Williams %R ChartNovo Nordisk A/S Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Novo Nordisk A/S.

Novo Nordisk A/S Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Novo Nordisk A/S. The current atr is 21.44.

Novo Nordisk A/S Daily Average True Range (ATR) ChartNovo Nordisk A/S Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Novo Nordisk A/S. The current obv is 76,452,993.

Novo Nordisk A/S Daily On-Balance Volume (OBV) ChartNovo Nordisk A/S Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Novo Nordisk A/S. The current mfi is 37.91.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Novo Nordisk A/S Daily Money Flow Index (MFI) ChartNovo Nordisk A/S Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Novo Nordisk A/S.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Novo Nordisk A/S Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Novo Nordisk A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.248
Ma 20Greater thanMa 50888.940
Ma 50Greater thanMa 100835.108
Ma 100Greater thanMa 200766.433
OpenGreater thanClose895.000
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Novo Nordisk A/S with someone you think should read this too:
  • Are you bullish or bearish on Novo Nordisk A/S? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Novo Nordisk A/S? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Novo Nordisk A/S

I send you an email if I find something interesting about Novo Nordisk A/S.


Comments

How you think about this?

Leave a comment

Stay informed about Novo Nordisk A/S.

Receive notifications about Novo Nordisk A/S in your mailbox!